About CutisBio

CutisBio — synthetic biology for everyday life.

CutisBio is a synthetic biology and advanced biomanufacturing company. We develop bio-based materials and products for health, beauty and fashion on the SAC platform, and pursue commercialisation with manufacturing and sales partners.

Mission & vision

We design living cells to make everyday life healthier and more beautiful.

Synthetic biology lets us design microbes that make useful molecules from renewable biomass instead of from petrochemicals or scarce natural extracts. CutisBio applies it to three markets where such materials are missing or hard to produce at scale: health, beauty and fashion.

Our platform, the Synbio Agile Commercialization (SAC) platform, is built to move quickly from a target molecule to an original strain, a patentable process and a manufacturable material, with evidence gathered at every step and manufacturing planned from the first experiment.

Vision

Our vision is to become a global pioneer in innovative specialty biomaterials that make people’s lives more beautiful and healthier.

  1. 01Cell
  2. 02Culture
  3. 03Fermentation
  4. 04Material

Business model

A technology company without a factory.

CutisBio develops original technology on the SAC platform: strains, processes and patents. Large-scale manufacturing and sales are carried out with external partners, so capital goes into the science rather than into plants.

Manufacturing partners produce materials and finished products from agreed processes. Sales partners handle distribution; the roles and supply scope are defined for each programme.

Partners

The companies that manufacture, ferment and sell what CutisBio develops.

Manufacturing partners · pharmaceutical materials

  • Daewoong Bio

Manufacturing and CDMO partners · bio specialty materials

  • GS Caltex

Manufacturing partners · finished skin boosters

  • Jetema
  • Cosmecca Korea
  • Cosmax
  • HK Kolmar

Sales partners

  • Jetema
  • Feizer
  • Stun Medical

Milestones

Key events since 2020.

Selected milestones from our founding in 2020 to today.

  1. 2020/06

    CutisBio founded in Seoul

    Incorporated on 30 June 2020 as a biofoundry-based synthetic biology start-up developing bio-based molecules and materials for health, beauty and fashion.

  2. 2024

    Skin-barrier booster ingredient licensed for exclusive supply

    A dependent patent assigned to a Korean skin-booster company together with an exclusive supply agreement for the ingredient; the partner’s product launched in April 2025.

  3. 2025

    CeraXosome hair booster launched

    First product of the booster line: developed on the SAC platform, produced by fermentation and evaluated in investigator-initiated clinical assessments before launch.

Leadership

Scientists, physicians and industry veterans.

A leadership team combining medicine, synthetic biology and biomanufacturing.

  • Wonwoo Choi, MD, PhD

    Founder & Chief Executive Officer

    Graduate of Seoul National University College of Medicine PhD in Medicine, Seoul National University Board Certified Dermatologist

  • Ji-Sook Hahn, PhD

    Chief Scientific Officer

    Professor of chemical and biological engineering, Seoul National University PhD in microbiology, Seoul National University Postdoctoral research at Michigan and Duke

  • Jaewoo Jang, MS

    Chief Technology Officer

    Former research-lab and business-development head at a leading industrial fermentation company MS in biological sciences, KAIST PhD coursework in microbiology, Seoul National University

The team

Synthetic biologists, microbiologists and physician-scientists, working alongside veterans of industrial strain development and mass production.

  • Synthetic biology

    Host, pathway and enzyme engineering for material development.

  • Microbiology and skin science

    Microbial resources and application-oriented research.

  • Process development

    Industrial fermentation, quality methods and manufacturing transfer.

Where we are going

A beauty and longevity synthetic biology company.

On the SAC platform we are expanding the portfolio of beauty and longevity biomaterials: new materials and original patents for hair ageing and hair loss, skin ageing, the lipid barrier and brightening, where current aesthetic treatments reach their limits.

Future product formats, including injectable boosters, remain development directions. We assess the evidence and requirements for each programme before defining its application and supply scope.

VSTER lab research directions

Next

See how the platform works, or start a conversation.

The SAC platform turns a target molecule into a strain, a process and a material. Explore it, or tell us about the material you need.